Workshop for implementing support tools to promote safety in the prescribing of oral contraceptives

实施支持工具以促进口服避孕药处方安全的讲习班

• 批准号: 10742446
• 负责人: Devin Bustin
• 金额: $ 5.4万
• 依托单位: OVARYIT, LLC
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-01 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10742446
• 关键词: Address; Adoption; Computer software; Contraceptive Agents; Contraceptive methods; Data; Educational workshop; Eligibility Determination; Feedback; Future; Grant; Health Services Accessibility; Healthcare Systems; Innovation Corps; Knowledge; Medical Technology; Medicine; Modification; Oral Contraceptives; Paper; Pharmacists; Pharmacy facility; Phase; Population; Pregnancy Rate; Process; Safety; Services; Small Business Innovation Research Grant; System; Technology; Testing; Time; United States; Woman; combat; commercialization; design; health inequalities; improved; insight; interest; member; patient safety; programs; recruit; support tools; unintended pregnancy; usability

SUMMARY The overall objective of our predicate SBIR Phase I grant, which commenced in September 2022, is to investigate the feasibility of pharmacists utilizing our proprietary OvaryIt software to prescribe contraceptives. Many states allow pharmacists to prescribe contraception, but the current paper-based process is inefficient and difficult to incorporate into daily practice for busy pharmacists. Therefore, even though many pharmacists are eligible to prescribe contraceptives, very few are actively offering these services. There continues to be an ongoing need for access to contraceptive services in the United States (US), with approximately 19 million women living in what is deemed a contraceptive desert. Because 90% of the population lives within 5 miles of a pharmacy, pharmacist-prescribed contraceptive services have the potential to dramatically increase access to care, decrease inequities in the health care system, and combat the high unintended pregnancy rate in the US. During Phase I, the OvaryIt Team has begun networking with numerous pharmacists with diverse backgrounds from across the US to gather insights and data. In addition to the primary feasibility objective, the team has recruited subject matter experts to assist in the creation of a comprehensive implementation package that addresses the barriers to the adoption of pharmacist-prescribed contraceptive services, determine the technological and operational requirements needed to successfully incorporate the solution into existing pharmacy workflows, and conduct usability testing to guide incremental improvements to the OvaryIt software. Early findings support our hypothesis that pharmacists are interested in providing contraceptive services, and they perceive that utilizing the OvaryIt software increases efficiency, patient safety, and the feasibility of incorporating contraceptive services into daily practice. Additionally, we received valuable feedback regarding potential modifications to the user interface that will guide improvements in the future system. OvaryIt, LLC has assembled a strong team with expertise in project management, contraceptive medicine, and medical technology design and implementation. All three members are committed to the time requirements of the program. The OvaryIt Team is willing to modify, adapt, and refine the overall commercialization strategy based on knowledge gained during the I-Corps Program.

总结 我们于2022年9月开始的同品种SBIR第一阶段资助的总体目标是 调查药剂师利用我们专有的OvaryIt软件开避孕药的可行性。 许多州允许药剂师开避孕处方，但目前基于纸张的过程效率低下 并且对于忙碌的药剂师来说难以纳入日常实践。因此，尽管许多药剂师 有资格开避孕药具处方的人很少，很少有人积极提供这些服务。依然不断 美国持续需要获得避孕服务，约有1900万人 生活在避孕沙漠中的女性因为90%的人口居住在 药房、药剂师处方的避孕服务有可能大大增加获得避孕服务的机会。 护理，减少医疗保健系统中的不公平现象，并打击高意外怀孕率， 我们 在第一阶段，OvaryIt团队已经开始与许多具有不同背景的药剂师建立联系 收集见解和数据。除了主要的可行性目标外，该团队还 征聘了专题专家，协助制定一套全面的执行方案， 解决采用药剂师处方避孕服务的障碍， 成功地将解决方案纳入现有的 药房工作流程，并进行可用性测试，以指导对OvaryIt软件的渐进式改进。 早期的研究结果支持我们的假设，即药剂师对提供避孕服务感兴趣， 他们认为，利用OvaryIt软件可以提高效率、患者安全性和可行性， 将避孕服务纳入日常实践。此外，我们还收到了有关以下方面的宝贵反馈： 可能对用户界面进行的修改，以指导未来系统的改进。 OvaryIt，LLC组建了一支强大的团队，拥有项目管理，避孕药物和 医疗技术设计与实施。所有三名成员都致力于时间要求， 节目OvaryIt团队愿意修改、调整和完善整体商业化战略 基于在I-Corps计划中获得的知识。